Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-10-09 | Moshe Manor was appointed to be the President and Chief Executive Officer of our company in September 2014 and his tenure is scheduled to commence on November 2, 2014. ... We believe Mr. Manor's qualifications to serve on our Board of Directors include his extensive experience in the life-science and pharmaceutical industry on a global scale. ... Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, amended ... Moshe Manor ... Dollar Value ($) 1,236,490 ... Option to Purchase 900,000 shares of common stock |
| 2015-10-01 | Moshe Manor has served as our President and Chief Executive Officer and as a director of our company since November 2014. ... The proxy statement does not list any compensation for Mr. Manor as a director separately from his executive compensation. |
| 2016-07-01 | Moshe Manor has served as our President and Chief Executive Officer and as a director of our company since November 2014. ... The proxy statement lists him as President and Chief Executive Officer, Director. No director compensation is listed for him in the director compensation table. |
| 2017-03-16 | Moshe Manor has served as our President and Chief Executive Officer and as a director of our Company since November 2014. ... Mr. Manor has served as our President and Chief Executive Officer and as a director of our Company since November 2014. ... Compensation table lists Moshe Manor as President and CEO but no director compensation is listed for him. |
| 2017-08-25 | IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to Certificate of Incorporation to be signed by its duly authorized President and Chief Executive Officer this day of , 2017. PROTALIX BIOTHERAPEUTICS, INC. By: Moshe Manor President and Chief Executive Officer |
| 2017-09-01 | IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to Certificate of Incorporation to be signed by its duly authorized President and Chief Executive Officer this day of , 2017. PROTALIX BIOTHERAPEUTICS, INC. By: Moshe Manor President and Chief Executive Officer |
| 2018-03-06 | Moshe Manor. Mr. Manor has served as our President and Chief Executive Officer and as a director of our Company since November 2014. ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2017. ... Moshe Manor is not listed in the director compensation table, indicating he is an employee director and does not receive separate director fees. |
| 2018-10-17 | Moshe ManorPresident and Chief Executive Officer |
| 2019-04-12 | Moshe Manor. Mr. Manor has served as our President and Chief Executive Officer and as a director of our Company since November 2014. ... The following table sets forth a summary for the fiscal years ended December 31, 2018, 2017 and 2016, respectively, of the cash and non-cash compensation awarded, paid or accrued by us or Protalix Ltd. to our President and Chief Executive Officer, ... Moshe Manor President and Chief Executive Officer 2018 Total ($) 717,654. |
Data sourced from SEC filings. Last updated: 2026-02-08